Seton 4 mg tablets contain ondansetron, an anti-emetic medicine. It works by blocking a body signal that triggers nausea and vomiting, and doctors use it in specific situations such as cancer treatment or after surgery.
There are 74 brands of Ondansetron listed in Bangladesh. 4 of them have a lower unit price than Seton. The lowest listed price is Periset 16 mg Suppository at ৳ 1 per unit.
What is Seton 4 mg Tablet?
Seton is a tablet made by Delta Pharma Limited that contains ondansetron 4 mg. Ondansetron belongs to a group called anti-emetic drugs. It blocks a serotonin signal in the body that can start a vomiting reflex, which is why it is used when nausea and vomiting are expected or have already started. Seton comes as a tablet in a pack of 3 x 10. Whether it suits a particular person, and how it should be taken, is decided by the doctor.
Uses of Seton
Seton is used to help prevent nausea and vomiting linked to chemotherapy for cancer, and to prevent and treat nausea and vomiting after an operation. It is also used to prevent nausea and vomiting caused by radiotherapy. It is not a general stomach medicine for every kind of sickness, so the doctor decides whether it fits the situation.
How to use Seton
Take Seton only as the doctor directs. Swallow the tablet with water unless the doctor advises otherwise. The doctor sets the dose and how long it should be taken, based on the reason it is prescribed and the person's condition. Do not change the amount or stop early on your own. If a dose is missed, ask the doctor or pharmacist what to do rather than guessing.
Side effects of Seton
Common side effects include headache, constipation and diarrhoea, and these are often mild or moderate. Some people notice a feeling of flushing or warmth, or hiccups. Unusual reactions such as rash, breathing problems, chest pain, a fast heartbeat or low potassium have been reported. Tell the doctor or pharmacist about any side effect that worries you or does not settle.
Safety and precautions
Do not take Seton if you have had an allergic reaction to ondansetron or any ingredient in the tablet. It must not be used with apomorphine. Tell the doctor if you have reacted badly to other similar anti-sickness medicines, or if you have had stomach or bowel surgery, because the medicine can hide signs of a bowel problem. Pregnancy and breastfeeding should be discussed with the doctor first, as should liver problems and other medicines you take.
Frequently asked questions
What does the 4 mg strength and tablet form mean?
The 4 mg shows how much ondansetron each tablet contains. The tablet form means it is swallowed. The pack is 3 x 10 tablets. The doctor decides how the tablets are used for each person.
What is Seton used for and what kind of medicine is it?
Seton is an anti-emetic medicine containing ondansetron. It is used to prevent and treat nausea and vomiting linked to chemotherapy, radiotherapy or an operation. It is not meant for every type of sickness, so the doctor decides if it is right.
Who should avoid Seton or ask the doctor first?
Anyone allergic to ondansetron or the tablet's ingredients should not take it, and it must not be combined with apomorphine. Ask the doctor first if you are pregnant or breastfeeding, have liver problems, have had bowel surgery, or take other medicines.
Ondansetron is a serotonin subtype 3 (5-HT3) receptor antagonist indicated:
Prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy.
Prevention and treatment of post-operative nausea and vomiting.
Prevention of radiotherapy-induced nausea and vomiting.
Pharmacology
Ondansetron is a potent, highly selective 5HT3 receptor-antagonist. Its precise mode of action in the control of nausea and vomiting is not known. Chemotherapeutic agents and radiotherapy may cause release of 5HT in the small intestine initiating a vomiting reflex by activating vagal afferents via 5HT3 receptors. Ondansetron blocks the initiation of this reflex. Activation of vagal afferents may also cause a release of 5HT in the area postrema, located on the floor of the fourth ventricle, and this may also promote emesis through a central mechanism. Thus, the effect of ondansetron in the management of the nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy is probably due to antagonism of 5HT3 receptors on neurons located both in the peripheral and central nervous system. The mechanisms of action in post-operative nausea and vomiting are not known but there may be common pathways with cytotoxic induced nausea and vomiting.
Dosage & Administration
Chemotherapy-Induced Nausea and Vomiting- Adults, Pediatric patients (6 months to 18 years):
8 mg tablet/orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Radiotherapy-Induced Nausea and Vomiting- Adults:
8 mg tablet/orodispersible tablet: Initial Dose: 8 mg orally 1 to 2 hours before radiotherapy. Post Radiotherapy: 8 mg orally every 8 hours for up to 5 days after a course of treatment.
4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Postoperative Nausea and Vomiting- Adults:
8 mg tablet/orodispersible tablet: 16 mg given as two 8 mg tablets
Chemotherapy-induced Nausea and Vomiting- Adults/Geriatric/Child of 12 years or over:
Highly emetogenic cancer chemotherapy: 30 ml (24 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy.
Moderate emetogenic cancer chemotherapy: 10 ml (8 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy. A further 10 ml dose should be administered after 8 hours of the first dose. One 10 ml dose should be administered twice a day (every 12 hours) for 1-2 days after completion of chemotherapy.
Pediatric (4-11 years): 5 ml (4 mg) Ondansetron Oral Solution should be taken 30 minutes before the start of chemotherapy. The other 2 doses should be taken 4 and 8 hours after the first dose. Then 5 ml oral solution should be administered 3 times a day (every 8 hours) for 1-2 days after completion of chemotherapy.
Oral solution:
Radiotherapy induced Nausea and Vomiting (Adults/Geriatric/Child of 12 years or over):
The recommended oral dosage: 10 ml (8 mg) Ondansetron Oral Solution 3 times daily.
For total body irradiation: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before each fraction of radiotherapy administered each day.
For single high-dose fraction radiotherapy to the abdomen: one 10 ml Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for 1 to 2 days after completion of radiotherapy.
For daily fractionated radiotherapy to the abdomen: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for each day radiotherapy is given.
Postoperative Nausea and Vomiting (Adults/Geriatric/Child of 12 years or over):
20 ml (16 mg) Ondansetron Oral Solution 1 hour before induction of anesthesia
Oral Soluble Film:
Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy:
Adult oral dose: 24 mg given successively as three 8 mg films 30 minutes before the start of chemotherapy.
Prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy:
Adults and pediatric patients 12 years of age and older: One 8 mg film 30 minutes before chemotherapy followed by an 8 mg dose 8 hours later. Administer one 8 mg film twice a day (every 12 hours) for 1 to 2 days after completion of chemotherapy.
Pediatric patients 4 through 11 years of age: One 4 mg film three times a day. Administer the first dose 30 minutes before chemotherapy, with subsequent doses 4 and 8 hours later. Administer one 4 mg film three times a day (every 8 hours) for 1 to 2 days after completion of chemotherapy.
Prevention of nausea and vomiting associated with radiotherapy: The adult dosage is one 8 mg film three times a day.
Postoperative nausea and vomiting: The adult dose is 16 mg given successively as two 8 mg films 1 hour before anesthesia.
Interaction
Ondansetron does not itself appear to induce or inhibit the cytochrome P-450 drug-metabolizing enzyme system of the liver. Because Ondansetron is metabolized by hepatic cytochrome P-450 drug-metabolizing enzymes, inducers or inhibitors of these enzymes may change the clearance and hence, the half-life of Ondansetron. On the basis of available data, no dosage adjustment of Ondasetron is recommended for patients on these drugs.
Contraindications
Contraindicated in patients known to have hypersensitivity to the drug or any of its components. Concomitant use of apomorphine.
Side Effects
Frequently reported adverse events were headache, constipation and diarrhea, but the majority have been mild or moderate in nature. In chemotherapy-induced nausea and vomiting, rash has occurred in approximately 1% of patients receiving Ondansetron. There also have been reports to a sensation of flushing or warmth, hiccups and liver enzyme abnormalities. Rare cases of anaphylaxis, brochospasm, tachycardia, angina (chest pain), hypokalemia, shortness of breath have also been reported, except for bronchospasm and anaphylaxis, the relationship to Ondansetron is unclear. There have been no evidence to extrapyramidal reactions, in rare case oculogyric crisis appearing alone, as well as with other dystonic reactions without definitive clinical evidence. In case of PONV, with the exception of headache, rates of these events were not significantly different in the Ondansetron and placebo groups.
Pregnancy & Lactation
Carcinogenic effects were not seen in 2-year studies in rats and mice with oral Ondansetron doses up to 10 and 30 mg/kg per day, respectively. Ondansetron was not mutagenic in standard tests for mutagenicity. Oral administration of Ondansetron up to 15 mg/kg per day did not affect fertility or general reproduction performance of male and female rats.
Reproduction studies have been performed in pregnant rats and rabbits at daily oral doses up to 15 and 30 mg/kg per day, respectively, and have revealed no evidence of impaired fertility or harm to the fetus due to Ondansetron. There are, however, no adequate and well-controlled studies in pregnant women. Ondansetron is excreted in the breast milk of rats. So caution should be exercised when Ondansetron is administered to a nursing women.
Precautions & Warnings
Hypersensitivity reactions have been reported in patients who have exhibited hypersensitivity to other selective 5-HT3 receptor antagonists. Ondansetron is not a drug that stimulates gastric or intestinal peristalsis. It should not be used instead of nasogastric suction. The use of Ondansetron in patients following abdominal surgery or in patients with chemotherapy-induced nausea and vomiting may mask a progressive ileus and/or gastric distension.
Storage Conditions
Store at temperature not exceeding 30ºC in a dry place. Protect from light and moisture.
Alternative brands of Ondansetron
Other brands with the same generic name, cheapest first.